{"id":1961,"date":"2024-09-11T20:14:46","date_gmt":"2024-09-11T20:14:46","guid":{"rendered":"https:\/\/onltherapeutics.com\/test\/?page_id=1961"},"modified":"2024-09-13T12:09:50","modified_gmt":"2024-09-13T12:09:50","slug":"board_stella-robertson-phd","status":"publish","type":"page","link":"https:\/\/onltherapeutics.com\/test\/board_stella-robertson-phd\/","title":{"rendered":"Board_Stella Robertson, PhD"},"content":{"rendered":"\n
\n
\n

Stella Robertson, PhD<\/h3>\n\n\n\n

Board Observer<\/p>\n<\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Dr. Robertson, co-founder and partner of Bios Partners, has over 35 years of experience in pharmaceutical research and development, including R&D strategies, project management, clinical trials, regulatory filings, product launch, market support, translational medicine and medical communication.<\/p>\n\n\n\n

She is a member and investor with Cowtown Angels and the owner of Arrochar Consulting LLC. As a former vice president of research and development at Alcon Laboratories Inc., she grew and led organizations responsible for the ophthalmic pipeline, otic pharmaceuticals and medical devices. During her tenure at Alcon, she and her colleagues successfully developed, registered and globally launched 16 ophthalmic medications and treatments for otitis media and nasal allergy.<\/p>\n\n\n\n

Dr. Robertson received a Ph.D. in biology-immunology from Johns Hopkins University, was an Arthritis Foundation post-doctoral research fellow at The University of Texas Southwestern Medical Center Dallas and completed the Program for Management Development at Harvard Business School. She is a fellow of the Association for Research in Vision and Ophthalmology (ARVO) and served on the ARVO Foundation board and the Women in Eye and Vision Research. She currently volunteers with The University of North Texas Health Science Center and ARVO entrepreneurial programs and serves on the boards of early-stage companies and the nonprofit incubator TECH Fort Worth.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
Back to Our Board<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n","protected":false},"excerpt":{"rendered":"

Stella Robertson, PhD Board Observer Dr. Robertson, co-founder and partner of Bios Partners, has over 35 years of experience in pharmaceutical research and development, including R&D strategies, project management, clinical trials, regulatory filings, product launch, market support, translational medicine and medical communication. She is a member and investor with Cowtown Angels and the owner of […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"blank","meta":{"ngg_post_thumbnail":0,"footnotes":""},"class_list":["post-1961","page","type-page","status-publish","hentry"],"featured_image_urls_v2":{"full":"","thumbnail":"","medium":"","medium_large":"","large":"","1536x1536":"","2048x2048":"","gform-image-choice-sm":"","gform-image-choice-md":"","gform-image-choice-lg":""},"post_excerpt_stackable_v2":"

Stella Robertson, PhD Board Observer Dr. Robertson, co-founder and partner of Bios Partners, has over 35 years of experience in pharmaceutical research and development, including R&D strategies, project management, clinical trials, regulatory filings, product launch, market support, translational medicine and medical communication. She is a member and investor with Cowtown Angels and the owner of Arrochar Consulting LLC. As a former vice president of research and development at Alcon Laboratories Inc., she grew and led organizations responsible for the ophthalmic pipeline, otic pharmaceuticals and medical devices. During her tenure at Alcon, she and her colleagues successfully developed, registered and globally…<\/p>\n","category_list_v2":"","author_info_v2":{"name":"theo@myriadweb.com","url":"https:\/\/onltherapeutics.com\/test\/author\/theomyriadweb-com\/"},"comments_num_v2":"0 comments","_links":{"self":[{"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/pages\/1961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/comments?post=1961"}],"version-history":[{"count":4,"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/pages\/1961\/revisions"}],"predecessor-version":[{"id":2070,"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/pages\/1961\/revisions\/2070"}],"wp:attachment":[{"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/media?parent=1961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}